A detailed history of Engineers Gate Manager LP transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 25,205 shares of DCTH stock, worth $293,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,205
Previous 10,650 136.67%
Holding current value
$293,386
Previous $89,000 155.06%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.36 - $11.0 $107,124 - $160,105
14,555 Added 136.67%
25,205 $227,000
Q2 2024

Aug 14, 2024

SELL
$4.47 - $8.37 $2,869 - $5,373
-642 Reduced 5.69%
10,650 $89,000
Q1 2024

May 15, 2024

BUY
$3.72 - $5.09 $42,006 - $57,476
11,292 New
11,292 $53,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $100M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.